ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

UICC Congress Urges World Commitment To Cancer Prevention.

July 14, 2006

Review Group Urges Increased Funding For NCI AIDS Drug Discovery Program

December 3, 1999

NCI Advises Five-Year Limit On Tamoxifen Use, in Letter To Doctors

December 8, 1995

New Concepts Being Developed By Organ Systems Groups Described

January 2, 1987

In Brief: Moertel To Deliver Karnofsky Lecture; Hopkins, Cold Spring Harbor Receive Bristol-Myers Awards

April 25, 1986

NIC Grants Appeals Process Explained

April 19, 1985